ES2182524T3 - Composiciones de hidroxiomeprazol y sus utilizaciones. - Google Patents
Composiciones de hidroxiomeprazol y sus utilizaciones.Info
- Publication number
- ES2182524T3 ES2182524T3 ES99922802T ES99922802T ES2182524T3 ES 2182524 T3 ES2182524 T3 ES 2182524T3 ES 99922802 T ES99922802 T ES 99922802T ES 99922802 T ES99922802 T ES 99922802T ES 2182524 T3 ES2182524 T3 ES 2182524T3
- Authority
- ES
- Spain
- Prior art keywords
- hydroxyomeprazole
- compositions
- omeprazole
- treatment
- hydroxyomeprazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- CMZHQFXXAAIBKE-UHFFFAOYSA-N 5'-hydroxyomeprazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(CO)C(OC)=C1C CMZHQFXXAAIBKE-UHFFFAOYSA-N 0.000 abstract 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 2
- 229960000381 omeprazole Drugs 0.000 abstract 2
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 201000008629 Zollinger-Ellison syndrome Diseases 0.000 abstract 1
- 230000008406 drug-drug interaction Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 201000000052 gastrinoma Diseases 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8425898P | 1998-05-05 | 1998-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2182524T3 true ES2182524T3 (es) | 2003-03-01 |
Family
ID=22183810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99922802T Expired - Lifetime ES2182524T3 (es) | 1998-05-05 | 1999-05-05 | Composiciones de hidroxiomeprazol y sus utilizaciones. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6294586B1 (enExample) |
| EP (1) | EP1082114B1 (enExample) |
| JP (1) | JP2003517434A (enExample) |
| AT (1) | ATE222764T1 (enExample) |
| AU (1) | AU748872B2 (enExample) |
| CA (1) | CA2330049A1 (enExample) |
| DE (1) | DE69902657T2 (enExample) |
| ES (1) | ES2182524T3 (enExample) |
| WO (1) | WO1999056746A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6420435B1 (en) * | 1999-11-01 | 2002-07-16 | Joe S. Wilkins, Jr. | Method for treating gastrointestinal disorders |
| US6987123B2 (en) * | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US7041706B2 (en) * | 2002-04-19 | 2006-05-09 | Wilkins Jr Joe S | Method for treating crohn's disease |
| JP2006516562A (ja) * | 2003-01-24 | 2006-07-06 | ステート オブ イスラエル、ミニストリー オブ アグリカルチャー | 抗酸化活性を増強するための相乗的な組成物及び方法 |
| WO2005032554A1 (en) | 2003-10-03 | 2005-04-14 | Astron Research Pvt. Ltd | A novel transmucosal delivery system |
| ES2281292B1 (es) * | 2006-03-08 | 2008-06-16 | Quimica Sintetica S.A. | Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden. |
-
1999
- 1999-05-05 JP JP2000546772A patent/JP2003517434A/ja active Pending
- 1999-05-05 WO PCT/US1999/009814 patent/WO1999056746A1/en not_active Ceased
- 1999-05-05 DE DE69902657T patent/DE69902657T2/de not_active Expired - Fee Related
- 1999-05-05 EP EP99922802A patent/EP1082114B1/en not_active Expired - Lifetime
- 1999-05-05 AT AT99922802T patent/ATE222764T1/de not_active IP Right Cessation
- 1999-05-05 CA CA002330049A patent/CA2330049A1/en not_active Abandoned
- 1999-05-05 ES ES99922802T patent/ES2182524T3/es not_active Expired - Lifetime
- 1999-05-05 AU AU39716/99A patent/AU748872B2/en not_active Ceased
-
2000
- 2000-10-30 US US09/699,597 patent/US6294586B1/en not_active Expired - Fee Related
-
2001
- 2001-08-10 US US09/927,954 patent/US6498171B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2330049A1 (en) | 1999-11-11 |
| ATE222764T1 (de) | 2002-09-15 |
| DE69902657D1 (de) | 2002-10-02 |
| EP1082114B1 (en) | 2002-08-28 |
| AU748872B2 (en) | 2002-06-13 |
| US6498171B2 (en) | 2002-12-24 |
| AU3971699A (en) | 1999-11-23 |
| JP2003517434A (ja) | 2003-05-27 |
| WO1999056746A1 (en) | 1999-11-11 |
| US6294586B1 (en) | 2001-09-25 |
| DE69902657T2 (de) | 2003-04-30 |
| EP1082114A1 (en) | 2001-03-14 |
| US20020010196A1 (en) | 2002-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE461237T1 (de) | Konjugierte copolymere aus dithienothiophen und vinylen oder acetylen | |
| IS7220A (is) | Latar af þætti XA og öðrum rað-próteösum sem tengjast storknunar keðjuverkun | |
| TR200101858T2 (tr) | JNK protein kinaz inhibitörleri olarak 4-ariloksindoller | |
| DE69717268D1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
| DK0699192T3 (da) | Substituerede oxazolylforbindelser til behandling af inflammation | |
| SE0102315D0 (sv) | Compounds | |
| DE60011515D1 (de) | Herstellung von Keramiksubstraten und ungesintertes Keramiksubstrat | |
| EA200201119A1 (ru) | Лиганды меланокортиновых рецепторов | |
| BR0111451A (pt) | Inibidores de serina protease | |
| WO2005099312A3 (en) | Triarylamine compounds for use as charge transport materials | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| ATE89028T1 (de) | Verwendung von zu elastomeren haertbaren organopolysiloxanmassen als klebstoffe. | |
| ATE44959T1 (de) | Polysiloxanzusammenstellungen mit oberflaechenbenetzungseigenschaften und daraus fabrizierte biomedizinische gegenstaende. | |
| DE60042401D1 (de) | Fab-i inhibitoren | |
| ATE321058T1 (de) | Stabilisatoren als polymerisationsinhibitoren von substituierten cyclotetrasiloxanen | |
| ATE497760T1 (de) | Filmueberzug fuer tabletten und kapletten | |
| DE60310767D1 (de) | PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN | |
| EE200100397A (et) | Kompositsioonid inflammatoorse reaktsiooni käitluseks | |
| ES2182524T3 (es) | Composiciones de hidroxiomeprazol y sus utilizaciones. | |
| DE69729001D1 (de) | Additiv zur regelung der vernetzungsgeschwindigkeit von polymerisierbaren zusammensetzungen | |
| DE69821530D1 (de) | Dihydrobenzifurane | |
| DE50312954D1 (de) | Härtung und trocknung von lacksystemen und druckfarben | |
| NO984950D0 (no) | Forbindelser med veksthormonfrigj°rende egenskaper | |
| PT1075262E (pt) | Processos e composicoes de desmetilpantoprazole | |
| ATE448282T1 (de) | Haftklebemasse |